HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 637-648 of 1,979
Drug study icon
CompletedEUCTR 2020-000405-83

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of iloperidone for 4 weeks in the treatment of patients with acute manic episodes associated wi...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
BipolarityHistorical research record
Countries
Bulgaria, Poland
Sponsor
Vanda Pharmaceuticals Inc.
Behavioral study icon
CompletedNCT05956340

Spoken Language in Mania

Official study title

Computational Analysis of Spoken Language in Mania

This study has finished and is no longer accepting participants.

In Rochester
BipolarityBehavioural studyAges 18–65
Countries
United States
Sponsor
Mayo Clinic
Drug study icon
CompletedNCT00643123

Allopurinol Add-on Treatment for Refractory Mania

Official study title

A Double-Blind, Placebo Controlled Augmentation Study With Allopurinol for Treatment Resistant Mania

This study has finished and is no longer accepting participants.

In Los Angeles
BipolarityMedication studyAges 18–70
Countries
United States
Sponsor
Cedars-Sinai Medical Center
Drug study icon
CompletedNCT00206778

Six Month study of Lamotrigine vs. Sodium Valproate for Treatment of Mixed Mania

Official study title

A Randomized Open-Label 6 Month Acute and Maintenance Trial of Lamotrigine vs. Standard of Care Sodium Valproate Monotherapy for Treatment of Mixed Mania.

This study has finished and is no longer accepting participants.

In New York
BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
Beth Israel Medical Center
Drug study icon
CompletedNCT01191918

AChE Inhibitor Donepezil for Bipolarity

Official study title

A Double-Blind, Placebo-Controlled Evaluation of The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute Mania

This study has finished and is no longer accepting participants.

Location not clearly listed
BipolarityMedication studyAges 18–60
Countries
Sponsor
Shanghai Mental Health Center
Device study icon
CompletedNCT01818622

Virtual Darkness as Additive Treatment in Mania

Official study title

Virtual Darkness as Additive Treatment in Mania- a Randomized Controlled Trial

This study has finished and is no longer accepting participants.

Multiple locations, including Haugesund
BipolarityDevice studyAges 18–70
Countries
Norway
Sponsor
Helse Fonna
Drug study icon
TerminatedNCT00329108

Ziprasidone And Olanzapine's Outcomes In Mania

Official study title

A Multicenter, Randomized, Double-Blind, Parallel Group Study, Comparing The Efficacy And Tolerability Of Ziprasidone (Zeldox, Geodon) vs. Olanzapine (Zyprexa) In The Treatment And Maintenance Of Response In Patients With Acute Mania

This study ended early.

Multiple locations, including Aachen
BipolarityMedication studyAges 18–65
Countries
Germany, Greece, Italy, + 2 others
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Other study type icon
CompletedNCT03181698

Brain Voxel-based Morphometry in Bipolar Mania

Official study title

Differences in Voxel-based Morphometry of Different Brain Structures in Patients With Mood Disorder Bipolar Mania in Comparison to Morphometry of Nrmal Controls

This study has finished and is no longer accepting participants.

In Asyut
BipolarityObservational study
Countries
Egypt
Sponsor
Assiut University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.